Skip to content

Large Head X3 Study

The Effect of Large Diameter Head to Prevent Dislocation, and of 3 rd Generation Highly Crosslinked Polyethylene to Reduce Wear in Computer Assisted Total Hip Arthroplasty.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02543437
Enrollment
120
Registered
2015-09-07
Start date
2010-07-31
Completion date
2019-07-31
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Joint Disease

Brief summary

The purpose of this study is to explore the benefit of X3 polyethlene inserts with larger diameter heads used in the Japanese population. Range of Motion (ROM) and lift-off distance for both 28mm, 32mm and 36mm in patients will be examined intraoperatively by using the Stryker computerized tomography (CT) based Navigation system. Another aspect of this study is to observe wear resistance performance of X3 over historical liner existing highly crosslinked polyethylene.

Interventions

DEVICETrident Acetabular X3 Insert

Sponsors

Stryker Japan K.K.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient who is a candidate for primary total hip arthroplasty (THA) with cementless acetabular and femoral components. 2. Patient who has diagnosis of degenerative joint disease and no bacterial infectious disease. 3. Patient whose age is 20 or over. 4. Patient who signed an Institutional Review Board (IRB)-approved, study specific Informed Patient Consent Form. 5. Patient who is willing and able to comply with postoperative scheduled evaluations.

Exclusion criteria

1. Patient who has a bacterial infectious disease or has a high risk of a bacterial infection. 2. Patient who requires revision surgery of a previously implanted total hip arthroplasty. 3. Patient who is morbidly obese, defined as having a Body Mass Index (BMI) \> 45. 4. Patient who is or may be pregnant female. 5. Patient who has a neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device. 6. Patient with diagnosed systemic disease (i.e. Paget's disease, renal osteodystrophy). 7. Patient who is immunologically suppressed or receiving chronic steroids. 8. Patient who is judged ineligible with specific reason by primary doctor.

Design outcomes

Primary

MeasureTime frameDescription
Range of Motion(ROM) (Degree)IntraoperativeMeasure and compare the ROM using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.
Lift Off Distance in Dislocation Maneuver(mm)IntraoperativeMeasure and compare the lift off distance in dislocation maneuver using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.

Secondary

MeasureTime frameDescription
Wear Rate(%)1 year, 2 years, 3 years and 5 years after surgeryRetrospective comparison of the wear amount over time between X3 liner and Crossfire insert.

Countries

Japan

Participant flow

Pre-assignment details

117 participants / 120 hips enrolled in study.

Participants by arm

ArmCount
X3 Liner
X3 28mm, 32mm and 36mm liner Trident Acetabular X3 Insert
117
Total117

Baseline characteristics

CharacteristicX3 Liner
Age, Continuous63.3 years
STANDARD_DEVIATION 9.1
Region of Enrollment
Japan
117 participants
Sex: Female, Male
Female
100 Participants
Sex: Female, Male
Male
17 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Lift Off Distance in Dislocation Maneuver(mm)

Measure and compare the lift off distance in dislocation maneuver using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.

Time frame: Intraoperative

Population: participants with available data : 100 hips in 100 participants.

ArmMeasureGroupValue (MEAN)Dispersion
X3 LinerLift Off Distance in Dislocation Maneuver(mm)Cup inclination-0.2 mmStandard Deviation 3.5
X3 LinerLift Off Distance in Dislocation Maneuver(mm)Cup anteversion1.4 mmStandard Deviation 5.3
X3 LinerLift Off Distance in Dislocation Maneuver(mm)Stem anteversion-1.2 mmStandard Deviation 6.4
Primary

Range of Motion(ROM) (Degree)

Measure and compare the ROM using femoral head trials of 36mm- and 28mm-diameter during intraoperative confirmation.

Time frame: Intraoperative

Population: Comparison between 28mm liner and 36mm line. Participants with available data : 119 hips in 117 participants.

ArmMeasureGroupValue (MEAN)Dispersion
X3 LinerRange of Motion(ROM) (Degree)Maximam Flexion2.6 DegreeStandard Deviation 4.5
X3 LinerRange of Motion(ROM) (Degree)Maximam Extension2.6 DegreeStandard Deviation 4.7
X3 LinerRange of Motion(ROM) (Degree)Maximam Abduction2.6 DegreeStandard Deviation 4.5
Secondary

Wear Rate(%)

Retrospective comparison of the wear amount over time between X3 liner and Crossfire insert.

Time frame: 1 year, 2 years, 3 years and 5 years after surgery

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026